Evidence map›Paper›PMID 35176025›Full record

ArticlePLoS neglected tropical diseases2022

Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network.

Maria-Jesus Pinazo, Mirko Rojas-Cortez, Ruth Saravia, Wilson Garcia-Ruiloba, Carlos Ramos, Jimy-Jose Pinto Rocha, Lourdes Ortiz, Mario Castellon, Nilce Mendoza-Claure, Daniel Lozano and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Maria-Jesus PinazoBarcelona Institute for Global Health (ISGlobal), Hospital Clínic- Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-4237-1075
Mirko Rojas-CortezFundación CEADES, Cochabamba, Bolivia.
Ruth SaraviaFundación CEADES, Cochabamba, Bolivia.
Wilson Garcia-RuilobaFundación CEADES, Cochabamba, Bolivia.
Carlos RamosFundación CEADES, Cochabamba, Bolivia.
Jimy-Jose Pinto RochaFundación CEADES, Cochabamba, Bolivia.ORCID 0000-0002-6884-4379
Lourdes OrtizFundación CEADES, Cochabamba, Bolivia.ORCID 0000-0001-5096-8069
Mario CastellonFundación CEADES, Cochabamba, Bolivia.
Nilce Mendoza-ClaureFundación CEADES, Cochabamba, Bolivia.
Daniel LozanoFundación CEADES, Cochabamba, Bolivia.ORCID 0000-0001-7774-5658
Faustino TorricoFundación CEADES, Cochabamba, Bolivia.
Joaquim GasconBarcelona Institute for Global Health (ISGlobal), Hospital Clínic- Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-5045-1585
Chagas Platform and Chagas Healthcare Network working group
Fundación PROINPA · BOCentro de Investigación en Red en Enfermedades Cardiovasculares · ESUniversidad Autónoma Juan Misael Saracho · BO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost people with chronic Chagas disease do not receive specific care and therefore are undiagnosed and do not receive accurate treatment. This manuscript discusses and evaluates a collaborative strategy to improve access to healthcare for patients with Chagas in Bolivia, a country with the highest prevalence of Chagas in the world.

methodsWith the aim of reinforcing the Chagas National Programme, the Bolivian Chagas Platform was born in 2009. The first stage of the project was to implement a vertical pilot program in order to introduce and consolidate a consensual protocol-based healthcare, working in seven centers (Chagas Platform Centers). From 2015 on the model was extended to 52 primary healthcare centers, through decentralized, horizontal scaling-up. To evaluate the strategy, we have used the WHO ExpandNet program.

resultsThe strategy has significantly increased the number of patients cared for, with 181,397 people at risk of having T. cruzi infection tested and 57,871 (31·9%) new diagnostics performed. In those with treatment criteria, 79·2% completed the treatment. The program has also trained a significant number of health personnel through the specific Chagas guidelines (67% of healthcare workers in the intervention area).

conclusionsAfter being recognized by the Chagas National Programme as a healthcare model aligned with national laws and priorities, the Bolivian platform of Chagas as an innovation, includes attributes that they have made it possible to expand the strategy at the national level and could also be adapted in other countries.

Indexed as

Antiparasitic AgentsBoliviaChagas DiseaseComprehensive Health CareHealth PersonnelHealth Services AccessibilityHumansNational Health ProgramsTrypanosoma cruziAntiparasitic Agents

Identifiers

PMID35176025
PMCPMC8853485
OpenAlexW4212905954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.